- Eli Lilly to Buy 3 Vaccine Developers The New York Times
- Exclusive | Lilly Agrees to Buy Trio of Vaccine Developers WSJ
- Lilly Goes on $20 Billion Buying Spree as Company Seeks Next Act Bloomberg.com
- LimmaTech Biologics to be Acquired by Lilly for Next-generation Vaccines Against Common Bacterial Infections Business Wire
- Three vaccine biotechs to be bought by Lilly for up to $3.8B Endpoints News
Source link ← Back to News